Syed Yousuf Zafar, MD

Associate Professor of Medicine
Associate Professor in the Sanford School of Public Policy
Affiliate, Duke Global Health Institute
Member of the Duke Cancer Institute
Member in the Duke Clinical Research Institute
Campus mail Duke Box 3505, Durham, NC 27710
Phone (919) 684-8111
Email address yousuf.zafar@duke.edu

Dr. Zafar is a health services researcher with a focus in improving care delivery for patients with advanced cancer. He has obtained advanced training in health services research and has participated in single-institution, multi-institution and national studies focusing on access to care, cost of care, and comparative effectiveness of care delivery between health systems. His primary area of interest is in the cost of cancer care. He has conducted institutional and national studies on how treatment-related costs impact cancer patients' experience. His current work in this arena is focused on patient preferences regarding cost-related communication and decision-making.

A second field of interest is palliative care. Dr. Zafar has collaborated with national and international palliative care leaders to improve the design and delivery of palliative care in cancer clinical trials. Methodologically, this work has centered around systematic literature reviews, iterative surveys, and prospective clinical trials.

Dr. Zafar is a member of the American Society of Clinical Oncology’s Health Disparities and Clinical Practice Guideline Committees. He is a member of the Alliance for Clinical Trials in Oncology's Health Disparities and Health Outcomes Committees. Dr. Zafar's work has been funded by the American Cancer Society, the HealthWell Foundation, the Duke Cancer Prevention and Control Program, the Duke Clinical Research Institute, and the CALGB Foundation.

In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 2005 - 2008
  • Resident, Medicine, University of Cincinnati, 2002 - 2005
  • M.D., University of Toledo, 2002

Publications

Yousuf Zafar, S, Tulsky, JA, and Abernethy, AP. "It's time to have 'The talk': Cost communication and patient-centered care." ONCOLOGY (United States) 28, no. 6 (January 1, 2014): 13-.

Scholars@Duke

Rangwala, F, Bendell, JC, Kozloff, MF, Arrowood, CC, Dellinger, A, Meadows, J, Tourt-Uhlig, S, Murphy, J, Meadows, KL, Starr, A, Broderick, S, Brady, JC, Cushman, SM, Morse, MA, Uronis, HE, Hsu, SD, Zafar, SY, Wallace, J, Starodub, AN, Strickler, JH, Pang, H, Nixon, AB, and Hurwitz, HI. "Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors." Investigational New Drugs 32, no. 4 (January 1, 2014): 700-709.

Full Text

De Boer, C, Niyonzima, N, Orem, J, Bartlett, J, and Zafar, SY. "Prognosis and delay of diagnosis among Kaposi's sarcoma patients in Uganda: a cross-sectional study." Infectious agents and cancer 9 (January 2014): 17-.

PMID
24904686
Full Text

De Boer, C, Niyonzima, N, Orem, J, Bartlett, J, and Zafar, S. "Prognosis and delay of diagnosis among Kaposi’s sarcoma patients in Uganda: a cross-sectional study." Infectious Agents and Cancer 9, no. 1 (2014): 17-17.

Full Text

Ubel, PA, Abernethy, AP, and Zafar, SY. "Full disclosure--out-of-pocket costs as side effects." N Engl J Med 369, no. 16 (October 17, 2013): 1484-1486.

PMID
24131175
Full Text

Zullig, LL, Peppercorn, JM, Schrag, D, Taylor, DH, Lu, Y, Samsa, G, Abernethy, AP, and Zafar, SY. "Financial Distress, Use of Cost-Coping Strategies, and Adherence to Prescription Medication Among Patients With Cancer." J Oncol Pract (August 20, 2013).

PMID
23981344
Full Text

Jackson, GL, Zullig, LL, Zafar, SY, Powell, AA, Ordin, DL, Gellad, ZF, Abbott, D, Schlosser, JM, Hersh, J, and Provenzale, D. "Using NCCN clinical practice guidelines in oncology to measure the quality of colorectal cancer care in the veterans health administration." J Natl Compr Canc Netw 11, no. 4 (April 1, 2013): 431-441.

PMID
23584346
Scholars@Duke

Zafar, SY, and Abernethy, AP. "Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?." ONCOLOGY-NEW YORK 27, no. 4 (April 2013): 253-+.

PMID
23781687
Scholars@Duke

Fouad, MN, Lee, JY, Catalano, PJ, Vogt, TM, Zafar, SY, West, DW, Simon, C, Klabunde, CN, Kahn, KL, Weeks, JC, and Kiefe, CI. "Enrollment of patients with lung and colorectal cancers onto clinical trials." J Oncol Pract 9, no. 2 (March 2013): e40-e47.

PMID
23814523
Full Text

Zafar, SY, Malin, JL, Grambow, SC, Abbott, DH, Kolimaga, JT, Zullig, LL, Weeks, JC, Ayanian, JZ, Kahn, KL, Ganz, PA, Catalano, PJ, West, DW, Provenzale, D, and Cancer Care Outcomes Research & Surveillance CanCORS Consortium, . "Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study." Cancer 119, no. 4 (February 15, 2013): 854-862.

PMID
22972673
Full Text

Pages